DC Advisory advised T Capital Partners on its acquisition of MicroBiopharm Japan

Background

• T Capital Partners (TCAP) is a private equity firm based in Tokyo, Japan
• MicroBiopharm Japan (MBJ) is a contract development manufacturing organization with strengths in microbial fermentation technology, engaged in the manufacturing and development of active pharmaceutical ingredients
• 80% of MBJ shares were owned by Mitsui & Co, a diversified global trading, investment, and service enterprise headquartered in Tokyo, Japan
• 20% of MBJ shares were owned by Toray Industries Inc, a Japan-based company that is primarily engaged in the integrated chemical industry to produce apparel and industrial materials

Process

• DC Advisory (DC) acted as a financial advisor to TCAP on the acquisition of all MBJ shares

Outcome

• TCAP will work with the MBJ management team to further enhance the company's corporate value by providing management know-how, human resources guidance, and support for planning and execution of M&A
• This transaction further demonstrates DC’s expertise within the healthcare space